Financhill
Back

NovaBay Pharmaceuticals Vs. Monopar Therapeutics Industry Stock Comparison

Sell
43

NBY
NovaBay Pharmaceuticals

Last Price:
$0.64
Seasonality Move:
-3.26%
Buy
62

MNPR
Monopar Therapeutics

Last Price:
$42.88
Seasonality Move:
-18.4%
Sell
43
NovaBay Pharmaceuticals (NBY) is a Sell

Is NovaBay Pharmaceuticals a Buy, Sell or Hold?

  • The current NovaBay Pharmaceuticals [NBY] share price is $0.66. The Score for NBY is 43, which is 14% below its historic median score of 50, and infers higher risk than normal.
  • NBY is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Monopar Therapeutics (MNPR) is a Buy

Is Monopar Therapeutics a Buy, Sell or Hold?

  • The current Monopar Therapeutics [MNPR] share price is $43.10. The Score for MNPR is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
  • MNPR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

NBY Stock Price Chart

What is NovaBay Pharmaceuticals's stock price today?

  • The NovaBay Pharmaceuticals share price today is $0.66
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and NBY is experiencing slight buying pressure.

MNPR Stock Price Chart

What is Monopar Therapeutics's stock price today?

  • The Monopar Therapeutics share price today is $43.10
    The current trend is moderately bullish and MNPR is experiencing buying pressure, which is a positive indicator for future bullish movement.

NBY Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 0 Buy
Relative Strength Index (14 RSI): 49.43 Sell
Chaikin Money Flow: 34267 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.65 - 0.73) Sell
Bollinger Bands (100): (0.58 - 0.72) Buy

MNPR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.09 Buy
Relative Strength Index (14 RSI): 54.79 Buy
Chaikin Money Flow: 42632 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (30.73 - 48.15) Buy
Bollinger Bands (100): (9.13 - 35.11) Buy

NBY Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 0.67 Sell
20-day SMA: 0.68 Sell
50-day SMA: 0.63 Buy
200-day SMA: 1.32 Sell
8-day EMA: 0.66 Sell
20-day EMA: 0.67 Sell
50-day EMA: 0.66 Sell
200-day EMA: 3.48 Sell

MNPR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 48.23 Sell
20-day SMA: 42.63 Buy
50-day SMA: 31.85 Buy
200-day SMA: 12.72 Buy
8-day EMA: 46.52 Sell
20-day EMA: 42.49 Buy
50-day EMA: 33.84 Buy
200-day EMA: 17.46 Buy

NovaBay Pharmaceuticals Earnings Growth & NBY Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.10 per share, a decrease next quarter of $0.00 per share, an increase this year of $2.40 per share, and an increase next year of $0.48 per share.

Monopar Therapeutics Earnings Growth & MNPR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.50 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.70 per share, and an increase next year of $2.24 per share.

NovaBay Pharmaceuticals Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Monopar Therapeutics Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):